Side-by-side comparison of AI visibility scores, market position, and capabilities
S&P Global (SPGI) reported $14.2B revenue in FY2024, up 14% YoY. Leading financial data and ratings company. S&P 500 index, credit ratings, market intelligence. HQ: New York, NY.
S&P Global Inc. is a leading provider of financial intelligence, credit ratings, data, research, and benchmarks, headquartered in New York City. Formed through the 2022 merger of S&P Global and IHS Markit, the combined company reported revenues of $14.2B in FY2024, up 14% year-over-year, with a market capitalization of approximately $160B. S&P Global is one of the few companies considered truly irreplaceable in the global financial system — it maintains the S&P 500 index, assigns credit ratings to sovereign and corporate debt globally, and provides the data infrastructure that powers financial markets.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.